# Effects of atrial fibrillation on cerebral perfusion and cognitive function: A systematic review

**Authors:** Pernille Borch, Stine Aagaard-Nilsen, Mathis Korseberg Stokke, Erik Lyseggen

PMC · DOI: 10.1016/j.ijcha.2026.101891 · International Journal of Cardiology. Heart & Vasculature · 2026-02-20

## TL;DR

Atrial fibrillation may reduce brain blood flow and worsen cognitive function, but evidence is limited and inconsistent.

## Contribution

A systematic review of cerebral perfusion and cognitive effects in atrial fibrillation, highlighting gaps in evidence.

## Key findings

- Most studies found reduced cerebral perfusion in atrial fibrillation compared to sinus rhythm.
- Cognitive performance was impaired in atrial fibrillation patients in multiple studies.
- Heart failure combined with atrial fibrillation may lead to greater perfusion decline.

## Abstract

Created in BioRender. BORCH, P. (2026) https://BioRender.com/yvbfpip. Abbreviations: AF, atrial fibrillation; HF, heart failure; SR, sinus rhythm; GRADE, Grades of Recommendation, Assessment, Development, and Evaluation.

•AF may impair cerebral perfusion and contribute to cognitive decline.•Most studies found reduced brain perfusion in AF compared with sinus rhythm.•AF was associated with impaired cognitive performance in multiple studies.•Limited evidence suggests greater perfusion decline in AF with heart failure.

AF may impair cerebral perfusion and contribute to cognitive decline.

Most studies found reduced brain perfusion in AF compared with sinus rhythm.

AF was associated with impaired cognitive performance in multiple studies.

Limited evidence suggests greater perfusion decline in AF with heart failure.

Atrial fibrillation (AF) has been associated with cognitive impairment. Impaired cerebral perfusion is a proposed mechanism, though evidence remains inconclusive, particularly in patients with concomitant heart failure (HF). We conducted a systematic review in accordance with PRISMA 2020 guidelines. PubMed and EMBASE were searched from database inception to May 9, 2025 for adult studies comparing cerebral perfusion in AF and sinus rhythm (SR). Risk of bias was assessed using ROBINS-E and ROBINS-I; certainty of evidence was graded using GRADE. Twenty-three studies were included (11 interventional, 1 observational, 11 cross-sectional). Measurement methods and effect sizes were heterogeneous. Most studies had serious/critical risk of bias, and certainty of evidence was low. Twenty-two studies concluded that AF may impair cerebral perfusion, while one found no such effect. Nine studies reported cognitive testing, and five demonstrated impaired performance in AF or improvement following SR restoration. In HF subgroup analyses (2 studies), perfusion was lower in HF patients with AF than those in SR. A third study found higher pulsatile index in HF patients with AF than those without HF, but no difference in peak, mean or diastolic cerebral blood flow velocities. Current clinical evidence suggests that AF may impair cerebral perfusion and contribute to cognitive decline. However, methodological limitations and heterogeneity limit the conclusions, and further longitudinal studies with standardized perfusion metrics are needed, including in concomitant HF where data are scarce.

## Linked entities

- **Diseases:** atrial fibrillation (MONDO:0004981), heart failure (MONDO:0005252)

## Full-text entities

- **Genes:** NPPB (natriuretic peptide B) [NCBI Gene 4879] {aka BNP, Iso-ANP}, VWF (von Willebrand factor) [NCBI Gene 7450] {aka F8VWF, VWD}, ACE (angiotensin I converting enzyme) [NCBI Gene 1636] {aka ACE1, CD143, DCP, DCP1}, CRP (C-reactive protein) [NCBI Gene 1401] {aka PTX1}, AP2B1 (adaptor related protein complex 2 subunit beta 1) [NCBI Gene 163] {aka ADTB2, AP105B, AP2-BETA, CLAPB1}
- **Diseases:** vascular disease (MESH:D014652), diabetes mellitus (MESH:D003920), reduced cerebral perfusion (MESH:D001523), AD (MESH:D000544), chronic kidney disease (MESH:D051436), Anxiety (MESH:D001007), Impaired cerebral perfusion (MESH:D002547), acute (MESH:D000208), mitral insufficiency (MESH:D008944), Stroke (MESH:D020521), Atrial fibrillation (MESH:D001281), ischemic heart disease (MESH:D017202), reduced cardiac output (MESH:D002303), ischemic stroke (MESH:D002544), acute myocardial infarction (MESH:D009203), CKD (MESH:D012080), Cerebrovascular Diseases (MESH:D002561), atrial flutter (MESH:D001282), HT (MESH:D006973), MCAD (MESH:C536038), cognitive dysfunction (MESH:D003072), HF (MESH:D006333), Depression (MESH:D003866), peripheral artery disease (MESH:D058729), TIA (MESH:D002546), coronary artery disease (MESH:D003324), dementia (MESH:D003704), impaired cardiac function (MESH:D006331), thromboembolic (MESH:D013923), aortic insufficiency (MESH:D001022)
- **Chemicals:** carbon (MESH:D002244), [15O (MESH:C000615263), oxygen (MESH:D010100), xenon (MESH:D014978), water (MESH:D014867), -terminal (-), calcium (MESH:D002118), CO2 (MESH:D002245)
- **Species:** Canis lupus familiaris (dog, subspecies) [taxon 9615], Homo sapiens (human, species) [taxon 9606]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12945524/full.md

## Figures

2 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12945524/full.md

## References

44 references — full list in the complete paper: https://tomesphere.com/paper/PMC12945524/full.md

---
Source: https://tomesphere.com/paper/PMC12945524